updated guidance on using corticosteroids for COVID-19. In July 2020, the European Medicines Agency (EMA) started reviewing results from the RECOVERY study arm that involved the use of dexamethasone in the treatment of patients with COVID-19 admitted to the hospital to provide an opinion on the results and in particular the potential use of dexamethasone for the treatment of adults with COVID-19. In September 2020, the EMA received an application for marketing authorization of dexamethasone for COVID-19. Society and culture Price Dexamethasone is inexpensive. In the United States a month of medication is typically priced less than . In India, a course of treatment for preterm labor is about . The drug is available in most areas of the world. Nonmedical use Dexamethasone is given in legal Bangladesh brothels to prostitutes not yet of legal age, causing weight gain aimed at making them appear older and healthier to customers and police. Dexamethasone and most glucocorticoids are banned by sporting bodies including the World Anti-Doping Agency. Veterinary use Combined with marbofloxacin CAS number 115550-35-1and clotrimazole, dexamethasone is available under the name Aurizon, CAS number 50-02-2, and used to treat difficult ear infections, especially in dogs. It can also be combined with trichlormethiazide to treat horses with swelling of distal limbs and general bruising. See also Dexamethasone suppression test References External links AbbVie brands Chemical substances for emergency medicine COVID-19 drug development CYP3A4 inducers Fluorinated corticosteroids Glucocorticoids Halohydrins Novartis brands Organofluorides Otologicals Peripherally selective drugs Pregnane X receptor agonists Pregnanes Wikipedia medicine articles ready to translate World Health Organization essential medicines